D I Conway1, M Purkayastha1, I G Chestnutt2. 1. School of Medicine, Dentistry and Nursing, University of Glasgow. 2. Cardiff University School of Dentistry.
Abstract
Objective: This review has three objectives, namely: (i) to discuss how oral cancer is and ought to be defined and recorded; (ii) to present up-to-date data on the incidence burden of the disease in the four countries of the UK, and review recent analyses of trends in the disease; and (iii) to summarise recent evidence on risk factors of the disease. Methods: Cancer definitions were clarified by the International Classification of Diseases accounting for anatomical and aetiological differences; descriptive epidemiology included international / UK literature review and information requests for incidence data from the UK cancer registries (2000-2016); analytical epidemiology focused on reviewing the findings of the International Head and Neck Cancer Epidemiology (INHANCE) consortium, which has pooled data from multiple case-control studies providing the best estimates of risk factors. Results: Emerging evidence of the role played by risk factors in different anatomical sites means that oral cavity cancer and oropharynx cancer should be considered distinct disease entities – and a standardised attribution of anatomical subsites will be helpful in ensuring consistency in how data are presented. In 2016, over 3,700 people were diagnosed with oral cavity cancer and over 3,500 people were diagnosed with oropharyngeal cancer in the UK. Incidence of oropharyngeal cancer is rapidly rising across the UK. Rates of oral cavity cancer are higher in Northern Ireland and higher still (and relatively stable) in Scotland, but rising in England and Wales. INHANCE data show that while the consumption of alcohol and tobacco are the prime risk factors for oral cavity and oropharyngeal cancers, they provide greater certainty in the preventive benefits of reducing these risk factors. The role played by other factors such as low socioeconomic status, genetics, oral health, and human papillomavirus (only for oropharyngeal cancer) have become clearer. Conclusions: This epidemiology provides a strong foundation for designing and managing both population and individual oral cavity and oropharyngeal cancer control strategies.
Objective: This review has three objectives, namely: (i) to discuss how oral cancer is and ought to be defined and recorded; (ii) to present up-to-date data on the incidence burden of the disease in the four countries of the UK, and review recent analyses of trends in the disease; and (iii) to summarise recent evidence on risk factors of the disease. Methods:Cancer definitions were clarified by the International Classification of Diseases accounting for anatomical and aetiological differences; descriptive epidemiology included international / UK literature review and information requests for incidence data from the UK cancer registries (2000-2016); analytical epidemiology focused on reviewing the findings of the International Head and Neck Cancer Epidemiology (INHANCE) consortium, which has pooled data from multiple case-control studies providing the best estimates of risk factors. Results: Emerging evidence of the role played by risk factors in different anatomical sites means that oral cavity cancer and oropharynx cancer should be considered distinct disease entities – and a standardised attribution of anatomical subsites will be helpful in ensuring consistency in how data are presented. In 2016, over 3,700 people were diagnosed with oral cavity cancer and over 3,500 people were diagnosed with oropharyngeal cancer in the UK. Incidence of oropharyngeal cancer is rapidly rising across the UK. Rates of oral cavity cancer are higher in Northern Ireland and higher still (and relatively stable) in Scotland, but rising in England and Wales. INHANCE data show that while the consumption of alcohol and tobacco are the prime risk factors for oral cavity and oropharyngeal cancers, they provide greater certainty in the preventive benefits of reducing these risk factors. The role played by other factors such as low socioeconomic status, genetics, oral health, and human papillomavirus (only for oropharyngeal cancer) have become clearer. Conclusions: This epidemiology provides a strong foundation for designing and managing both population and individual oral cavity and oropharyngeal cancer control strategies.
Authors: Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi Journal: JAMA Date: 2012-01-26 Impact factor: 56.272
Authors: David I Conway; Mia Hashibe; Paolo Boffetta; Victor Wunsch-Filho; Joshua Muscat; Carlo La Vecchia; Deborah M Winn Journal: Oral Oncol Date: 2009-05-12 Impact factor: 5.337
Authors: V Edefonti; M Hashibe; F Ambrogi; M Parpinel; F Bravi; R Talamini; F Levi; G Yu; H Morgenstern; K Kelsey; M McClean; S Schantz; Z Zhang; S Chuang; P Boffetta; C La Vecchia; A Decarli Journal: Ann Oncol Date: 2011-11-28 Impact factor: 32.976
Authors: Mia M Gaudet; Andrew F Olshan; Shu-Chun Chuang; Julien Berthiller; Zuo-Feng Zhang; Jolanta Lissowska; David Zaridze; Deborah M Winn; Qingyi Wei; Renato Talamini; Neolilia Szeszenia-Dabrowska; Erich M Sturgis; Stephen M Schwartz; Peter Rudnai; Jose Eluf-Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Elena Matos; Alexandru Bucur; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Karl Kelsey; Rolando Herrero; Richard B Hayes; Silva Franceschi; Victor Wunsch-Filho; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Luigino Dal Maso; Maria Paula Curado; Chu Chen; Xavier Castellsague; Simone Benhamou; Paolo Boffetta; Paul Brennan; Mia Hashibe Journal: Int J Epidemiol Date: 2010-02-01 Impact factor: 7.196
Authors: Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison Journal: N Engl J Med Date: 2007-05-10 Impact factor: 91.245
Authors: Julien Berthiller; Kurt Straif; Antonio Agudo; Wolfgang Ahrens; Alexandre Bezerra Dos Santos; Stefania Boccia; Gabriella Cadoni; Cristina Canova; Xavier Castellsague; Chu Chen; David Conway; Maria Paula Curado; Luigino Dal Maso; Alexander W Daudt; Eleonora Fabianova; Leticia Fernandez; Silvia Franceschi; Erica E Fukuyama; Richard B Hayes; Claire Healy; Rolando Herrero; Ivana Holcatova; Karl Kelsey; Kristina Kjaerheim; Sergio Koifman; Pagona Lagiou; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Jolanta Lissowska; Tatiana Macfarlane; Dana Mates; Michael McClean; Ana Menezes; Franco Merletti; Hal Morgenstern; Joshua Muscat; Andrew F Olshan; Mark Purdue; Heribert Ramroth; Peter Rudnai; Stephen M Schwartz; Diego Serraino; Oxana Shangina; Elaine Smith; Erich M Sturgis; Neonila Szeszenia-Dabrowska; Peter Thomson; Thomas L Vaughan; Marta Vilensky; Qingyi Wei; Deborah M Winn; Victor Wünsch-Filho; Zuo-Feng Zhang; Ariana Znaor; Gilles Ferro; Paul Brennan; Paolo Boffetta; Mia Hashibe; Yuan-Chin Amy Lee Journal: Int J Epidemiol Date: 2015-07-30 Impact factor: 7.196
Authors: Manuela Marron; Paolo Boffetta; Zuo-Feng Zhang; David Zaridze; Victor Wünsch-Filho; Deborah M Winn; Qingyi Wei; Renato Talamini; Neonila Szeszenia-Dabrowska; Erich M Sturgis; Elaine Smith; Stephen M Schwartz; Peter Rudnai; Mark P Purdue; Andrew F Olshan; Jose Eluf-Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Michael McClean; Elena Matos; Ioan Nicolae Mates; Jolanta Lissowska; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Karl Kelsey; Rolando Herrero; Richard B Hayes; Silvia Franceschi; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Luigino Dal Maso; Maria Paula Curado; Gabriella Cadoni; Chu Chen; Xavier Castellsague; Stefania Boccia; Simone Benhamou; Gilles Ferro; Julien Berthiller; Paul Brennan; Henrik Møller; Mia Hashibe Journal: Int J Epidemiol Date: 2009-10-05 Impact factor: 7.196
Authors: Mia Hashibe; Paul Brennan; Simone Benhamou; Xavier Castellsague; Chu Chen; Maria Paula Curado; Luigino Dal Maso; Alexander W Daudt; Eleonora Fabianova; Leticia Fernandez; Victor Wünsch-Filho; Silvia Franceschi; Richard B Hayes; Rolando Herrero; Sergio Koifman; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Dana Mates; Elena Matos; Ana Menezes; Joshua Muscat; Jose Eluf-Neto; Andrew F Olshan; Peter Rudnai; Stephen M Schwartz; Elaine Smith; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Renato Talamini; Qingyi Wei; Deborah M Winn; David Zaridze; Witold Zatonski; Zuo-Feng Zhang; Julien Berthiller; Paolo Boffetta Journal: J Natl Cancer Inst Date: 2007-05-16 Impact factor: 13.506
Authors: Jan E Clarkson; Nigel B Pitts; Beatriz Goulao; Dwayne Boyers; Craig R Ramsay; Ruth Floate; Hazel J Braid; Patrick A Fee; Fiona S Ord; Helen V Worthington; Marjon van der Pol; Linda Young; Ruth Freeman; Jill Gouick; Gerald M Humphris; Fiona E Mitchell; Alison M McDonald; John Dt Norrie; Kirsty Sim; Gail Douglas; David Ricketts Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014
Authors: Richard Holliday; Bosun Hong; Elaine McColl; Jonathan Livingstone-Banks; Philip M Preshaw Journal: Cochrane Database Syst Rev Date: 2021-02-19
Authors: Deborah Gomes de Miranda Vargas; Livia Fernandes Probst; Amanda Ramos da Cunha; Elaine Pereira da Silva Tagliaferro; Edílson José Zafalon; Paulo Zárate-Pereira; Alessandro Diogo De-Carli Journal: BMC Oral Health Date: 2021-06-18 Impact factor: 2.757
Authors: Inger-Heidi Bjerkli; Olav Jetlund; Gunnhild Karevold; Ása Karlsdóttir; Ellen Jaatun; Lars Uhlin-Hansen; Oddveig G Rikardsen; Elin Hadler-Olsen; Sonja E Steigen Journal: PLoS One Date: 2020-01-16 Impact factor: 3.240